Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 342

1.

Treatment strategies in early rheumatoid arthritis methotrexate management: Results from a prospective cohort.

Moura CS, Schieir O, Valois MF, Thorne C, Bartlett SJ, Pope JE, Hitchon CA, Boire G, Haraoui B, Hazlewood GS, Keystone EC, Tin D, Bykerk VP, Bernatsky S; Canadian Early Arthritis Cohort (CATCH) Investigators.

Arthritis Care Res (Hoboken). 2019 May 21. doi: 10.1002/acr.23927. [Epub ahead of print]

PMID:
31112011
2.

A Meta-Analysis of Treatment for Primary Sjögren's Syndrome.

Chu LL, Cui K, Pope JE.

Arthritis Care Res (Hoboken). 2019 May 6. doi: 10.1002/acr.23917. [Epub ahead of print]

PMID:
31058469
3.

Guest Editorial: Physician Guidance on the Use of Off-Labeled Drugs in Intrathecal Drug Delivery Systems for Chronic Pain.

Deer T, Kim P, Pope JE, Hayek S, McDowell G, Mekhail N, Diwan S, Saulino M, Moeschler S, Schultz D, Gritsenko K, Prager J, Peterson EA, Staats P, Poree L, Fishman MA, Vallejo R, Calodney A, Slavin K, de Leon Cassadala O, Levy R, Buvanendran A, Sitzman BT, Sayed D, Ferrante FM, Kloth D, Gilligan CJ, Kapural L, Kloster DR, Leong M, Rosenow JM, Lamer TJ, Stearns L.

Neuromodulation. 2019 Apr 30. doi: 10.1111/ner.12961. [Epub ahead of print] No abstract available.

PMID:
31039292
4.

Comparison of Janus kinase inhibitors in the treatment of rheumatoid arthritis: a systemic literature review.

Jegatheeswaran J, Turk M, Pope JE.

Immunotherapy. 2019 Jun;11(8):737-754. doi: 10.2217/imt-2018-0178. Epub 2019 Apr 8.

PMID:
30955397
5.

Evolving patterns of reactive arthritis.

Hayes KM, Hayes RJP, Turk MA, Pope JE.

Clin Rheumatol. 2019 Mar 27. doi: 10.1007/s10067-019-04522-4. [Epub ahead of print]

PMID:
30919146
6.

Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort.

Wu W, Jordan S, Graf N, de Oliveira Pena J, Curram J, Allanore Y, Matucci-Cerinic M, Pope JE, Denton CP, Khanna D, Distler O; EUSTAR Collaborators.

Ann Rheum Dis. 2019 May;78(5):648-656. doi: 10.1136/annrheumdis-2018-213455. Epub 2019 Mar 9.

7.

Is it time to banish composite measures for remission in RA?

Pope JE, Michaud K.

Arthritis Care Res (Hoboken). 2019 Mar 1. doi: 10.1002/acr.23862. [Epub ahead of print]

PMID:
30821934
8.

A comparison between childhood and adult onset systemic lupus erythematosus adjusted for ethnicity from the 1000 Canadian Faces of Lupus Cohort.

Kim H, Levy DM, Silverman ED, Hitchon C, Bernatsky S, Pineau C, Smith CD, Tucker L, Petty R, Arbillaga H, Zummer M, Hudson M, Fortin P, Huber AM, Chedeville G, Peschken C, Pope JE.

Rheumatology (Oxford). 2019 Feb 25. pii: kez006. doi: 10.1093/rheumatology/kez006. [Epub ahead of print]

PMID:
30805629
9.

Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary.

Papp KA, Haraoui B, Kumar D, Marshall JK, Bissonnette R, Bitton A, Bressler B, Gooderham M, Ho V, Jamal S, Pope JE, Steinhart AH, Vinh DC, Wade J.

J Rheumatol. 2019 Feb 1. pii: jrheum.180784. doi: 10.3899/jrheum.180784. [Epub ahead of print]

10.

Patient-reported outcome instruments for assessing Raynaud's phenomenon in systemic sclerosis: A SCTC Vascular Working Group Report.

Pauling JD, Frech TM, Hughes M, Gordon JK, Domsic RT, Anderson ME, Ingegnoli F, McHugh NJ, Johnson SR, Hudson M, Boin F, Ong VH, Matucci-Cerinic M, Altorok N, Scolnik M, Nikpour M, Shah A, Pope JE, Khanna D, Herrick AL.

J Scleroderma Relat Disord. 2018 Oct;3(3):249-252. doi: 10.1177/2397198318774307. Epub 2018 May 24.

11.

Reply.

Pope JE.

Arthritis Rheumatol. 2019 May;71(5):834-835. doi: 10.1002/art.40836. Epub 2019 Mar 20. No abstract available.

PMID:
30636095
12.

Advanced methods of spinal stimulation in the treatment of chronic pain: pulse trains, waveforms, frequencies, targets, and feedback loops.

Maheshwari A, Pope JE, Deer TR, Falowski S.

Expert Rev Med Devices. 2019 Feb;16(2):95-106. doi: 10.1080/17434440.2019.1567325. Epub 2019 Jan 21.

PMID:
30625000
13.

Comparison of Paresthesia Coverage of Patient's Pain: Dorsal Root Ganglion vs. Spinal Cord Stimulation. An ACCURATE Study Sub-Analysis.

Deer TR, Levy RM, Kramer J, Poree L, Amirdelfan K, Grigsby E, Staats P, Burgher AH, Scowcroft J, Golovac S, Kapural L, Paicius R, Pope JE, Samuel S, Porter McRoberts W, Schaufele M, Burton AW, Raza A, Agnesi F, Mekhail N.

Neuromodulation. 2019 Jan 9. doi: 10.1111/ner.12920. [Epub ahead of print]

PMID:
30624003
14.

Prescribing Opioids for Severe Hip and Knee Osteoarthritis Varies Widely in the United States: The Devil Is in the Details.

Pope JE.

Arthritis Rheumatol. 2019 May;71(5):659-661. doi: 10.1002/art.40833. Epub 2019 Apr 2. No abstract available.

PMID:
30614218
15.

IgG4-Related Disease, A Single-Center Experience.

Fernández-Codina A, Haig S, Pope JE, Barra L.

J Clin Rheumatol. 2018 Dec 20. doi: 10.1097/RHU.0000000000000970. [Epub ahead of print] No abstract available.

PMID:
30585995
16.

Redefining Success: Longitudinal Patient Reported Outcome Measures and the Importance of Psychometric Testing for Optimization in Neuromodulation.

Pope JE, Fishman M.

Neuromodulation. 2019 Jan;22(1):119-120. doi: 10.1111/ner.12907. Epub 2018 Dec 13. No abstract available.

PMID:
30548940
17.

Associations Between Methotrexate Use and the Risk of Cardiovascular Events in Patients with Elderly-onset Rheumatoid Arthritis.

Widdifield J, Abrahamowicz M, Paterson JM, Huang A, Thorne JC, Pope JE, Kuriya B, Beauchamp ME, Bernatsky S.

J Rheumatol. 2019 May;46(5):467-474. doi: 10.3899/jrheum.180427. Epub 2018 Dec 1.

PMID:
30504508
18.

ACPA and RF as predictors of sustained clinical remission in patients with rheumatoid arthritis: data from the Ontario Best practices Research Initiative (OBRI).

Pope JE, Movahedi M, Rampakakis E, Cesta A, Sampalis JS, Keystone E, Thorne C, Bombardier C.

RMD Open. 2018 Nov 5;4(2):e000738. doi: 10.1136/rmdopen-2018-000738. eCollection 2018.

19.

Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies.

Papp KA, Haraoui B, Kumar D, Marshall JK, Bissonnette R, Bitton A, Bressler B, Gooderham M, Ho V, Jamal S, Pope JE, Steinhart AH, Vinh DC, Wade J.

J Cutan Med Surg. 2019 Jan/Feb;23(1):50-74. doi: 10.1177/1203475418811335. Epub 2018 Nov 21.

20.

The MIST Guidelines: The Lumbar Spinal Stenosis Consensus Group Guidelines for Minimally Invasive Spine Treatment.

Deer TR, Grider JS, Pope JE, Falowski S, Lamer TJ, Calodney A, Provenzano DA, Sayed D, Lee E, Wahezi SE, Kim C, Hunter C, Gupta M, Benyamin R, Chopko B, Demesmin D, Diwan S, Gharibo C, Kapural L, Kloth D, Klagges BD, Harned M, Simopoulos T, McJunkin T, Carlson JD, Rosenquist RW, Lubenow TR, Mekhail N.

Pain Pract. 2019 Mar;19(3):250-274. doi: 10.1111/papr.12744. Epub 2018 Dec 2.

PMID:
30369003
21.
22.

The Neuromodulation Appropriateness Consensus Committee on Best Practices for Dorsal Root Ganglion Stimulation.

Deer TR, Pope JE, Lamer TJ, Grider JS, Provenzano D, Lubenow TR, FitzGerald JJ, Hunter C, Falowski S, Sayed D, Baranidharan G, Patel NK, Davis T, Green A, Pajuelo A, Epstein LJ, Harned M, Liem L, Christo PJ, Chakravarthy K, Gilmore C, Huygen F, Lee E, Metha P, Nijhuis H, Patterson DG, Petersen E, Pilitsis JG, Rowe JJ, Rupert MP, Skaribas I, Sweet J, Verrills P, Wilson D, Levy RM, Mekhail N.

Neuromodulation. 2019 Jan;22(1):1-35. doi: 10.1111/ner.12845. Epub 2018 Sep 24. Review.

PMID:
30246899
23.

Intrathecal Therapy for Chronic Pain: A Review of Morphine and Ziconotide as Firstline Options.

Deer TR, Pope JE, Hanes MC, McDowell GC.

Pain Med. 2019 Apr 1;20(4):784-798. doi: 10.1093/pm/pny132.

24.

Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic Review.

Emery P, Pope JE, Kruger K, Lippe R, DeMasi R, Lula S, Kola B.

Adv Ther. 2018 Oct;35(10):1535-1563. doi: 10.1007/s12325-018-0757-2. Epub 2018 Aug 20. Review.

25.

Monitoring of Osteonecrosis in Systemic Lupus Erythematosus: A Systematic Review and Metaanalysis.

Hussein S, Suitner M, Béland-Bonenfant S, Baril-Dionne A, Vandermeer B, Santesso N, Keeling S, Pope JE, Fifi-Mah A, Bourré-Tessier J.

J Rheumatol. 2018 Oct;45(10):1462-1476. doi: 10.3899/jrheum.170837. Epub 2018 Jul 1.

26.

Pragmaticism of Randomized Controlled Trials of Biologic Treatment With Methotrexate in Rheumatoid Arthritis: A Systematic Review.

Choi MY, Barnabe C, Barber CE, Bykerk V, Pope JE, Hazlewood GS.

Arthritis Care Res (Hoboken). 2019 May;71(5):620-628. doi: 10.1002/acr.23620. Epub 2019 Apr 10.

PMID:
29908014
27.

Appropriate cardiovascular disease risk assessment in systemic lupus erythematosus may be lacking in rheumatology practice.

Esmaeilbeigi F, Pope JE.

Clin Exp Rheumatol. 2018 Jul-Aug;36(4):526-532. Epub 2018 May 28.

PMID:
29846162
28.

Treatment Algorithms for Systemic Sclerosis According to Experts.

Fernández-Codina A, Walker KM, Pope JE; Scleroderma Algorithm Group.

Arthritis Rheumatol. 2018 Nov;70(11):1820-1828. doi: 10.1002/art.40560. Epub 2018 Sep 17.

PMID:
29781586
29.

A systematic review of viral exposures as a risk for rheumatoid arthritis.

Kudaeva FM, Speechley MR, Pope JE.

Semin Arthritis Rheum. 2019 Feb;48(4):587-596. doi: 10.1016/j.semarthrit.2018.03.011. Epub 2018 Mar 21.

PMID:
29747994
30.

Editorial: Safety of Tumor Necrosis Factor Inhibitors in Pregnancy.

Pope JE.

Arthritis Rheumatol. 2018 Sep;70(9):1359-1363. doi: 10.1002/art.40540. Epub 2018 Jul 23. No abstract available.

PMID:
29733552
31.

Repeat Testing of Antibodies and Complements in Systemic Lupus Erythematosus: When Is It Enough?

Raissi TC, Hewson C, Pope JE.

J Rheumatol. 2018 Jun;45(6):827-834. doi: 10.3899/jrheum.161365. Epub 2018 Apr 15.

PMID:
29657153
32.

Randomized Trials, Meta-Analyses, and Systematic Reviews: Using Examples from Rheumatology.

Pope JE, Hazlewood GS.

Rheum Dis Clin North Am. 2018 May;44(2):295-305. doi: 10.1016/j.rdc.2018.01.006. Review.

PMID:
29622296
33.

Mentoring women in medicine: a personal perspective.

Pope JE.

Lancet. 2018 Feb 10;391(10120):520-521. doi: 10.1016/S0140-6736(18)30243-5. No abstract available.

PMID:
29617225
34.

Physician global assessments for disease activity in rheumatoid arthritis are all over the map!

Turk M, Pope JE.

RMD Open. 2018 Feb 21;4(1):e000578. doi: 10.1136/rmdopen-2017-000578. eCollection 2018.

35.

High Adherence to System-Level Performance Measures for Rheumatoid Arthritis in a National Early Arthritis Cohort Over Eight Years.

Barber CEH, Schieir O, Lacaille D, Marshall DA, Barnabe C, Hazlewood G, Thorne JC, Ahluwalia V, Bartlett SJ, Boire G, Haraoui B, Hitchon C, Keystone E, Tin D, Pope JE, Denning L, Bykerk VP; Canadian Early Arthritis Cohort Investigators.

Arthritis Care Res (Hoboken). 2018 Jun;70(6):842-850. doi: 10.1002/acr.23439. Epub 2018 Mar 25.

36.

Factors influencing early referral, early diagnosis and management in patients with diffuse cutaneous systemic sclerosis.

Distler O, Allanore Y, Denton CP, Matucci-Cerinic M, Pope JE, Hinzmann B, Davies S, de Oliveira Pena J, Khanna D.

Rheumatology (Oxford). 2018 May 1;57(5):813-817. doi: 10.1093/rheumatology/kex504.

37.

Stress in patients diagnosed with rheumatoid arthritis compared to chronic pain.

Rice DB, Mehta S, Serrato J, Pope JE, Harth M, Sequeira K, Morley-Forster P, Shapiro AP, Teasell RW.

Rehabil Psychol. 2017 Nov;62(4):571-579. doi: 10.1037/rep0000103.

PMID:
29265872
38.

Two-year Efficacy and Safety of Subcutaneous Tocilizumab in Combination with Disease-modifying Antirheumatic Drugs Including Escalation to Weekly Dosing in Rheumatoid Arthritis.

Kivitz A, Olech E, Borofsky MA, Zazueta B, Navarro-Sarabia F, Radominski SC, Merrill JT, Pacheco-Tena C, Pei J, Nasmyth-Miller C, Pope JE.

J Rheumatol. 2018 Apr;45(4):456-464. doi: 10.3899/jrheum.161539. Epub 2017 Dec 15.

39.

Association of Opioid Usage with Spinal Cord Stimulation Outcomes.

Sharan AD, Riley J, Falowski S, Pope JE, Connolly AT, Karst E, Dalal N, Provenzano DA.

Pain Med. 2018 Apr 1;19(4):699-707. doi: 10.1093/pm/pnx262.

PMID:
29244102
40.

Overweight, Obesity, and the Likelihood of Achieving Sustained Remission in Early Rheumatoid Arthritis: Results From a Multicenter Prospective Cohort Study.

Schulman E, Bartlett SJ, Schieir O, Andersen KM, Boire G, Pope JE, Hitchon C, Jamal S, Thorne JC, Tin D, Keystone EC, Haraoui B, Goodman SM, Bykerk VP; CATCH Investigators.

Arthritis Care Res (Hoboken). 2018 Aug;70(8):1185-1191. doi: 10.1002/acr.23457. Epub 2018 Jul 13.

PMID:
29193840
41.

Treatment patterns in rheumatoid arthritis after discontinuation of methotrexate: data from the Ontario Best Practices Research Initiative (OBRI).

Pope JE, Rampakakis E, Movahedi M, Cesta A, Li X, Couto S, Sampalis JS, Bombardier C; and the Ontario Best Practices Research Initiative investigators.

Clin Exp Rheumatol. 2018 Mar-Apr;36(2):215-222. Epub 2017 Oct 23.

42.

Editorial: Bench to Bedside-and Back Again: Finding the Goldilocks Zone Within the Scleroderma Universe.

Pope JE, Lee JJ, Denton CP.

Arthritis Rheumatol. 2018 Feb;70(2):155-156. doi: 10.1002/art.40373. Epub 2017 Dec 29. No abstract available.

43.

Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis.

Arnold MB, Khanna D, Denton CP, van Laar JM, Frech TM, Anderson ME, Baron M, Chung L, Fierlbeck G, Lakshminarayanan S, Allanore Y, Riemekasten G, Steen V, Müller-Ladner U, Spotswood H, Burke L, Siegel J, Jahreis A, Furst DE, Pope JE.

Rheumatology (Oxford). 2018 Jan 1;57(1):152-157. doi: 10.1093/rheumatology/kex396.

44.

Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate).

Khanna D, Denton CP, Lin CJF, van Laar JM, Frech TM, Anderson ME, Baron M, Chung L, Fierlbeck G, Lakshminarayanan S, Allanore Y, Pope JE, Riemekasten G, Steen V, Müller-Ladner U, Spotswood H, Burke L, Siegel J, Jahreis A, Furst DE.

Ann Rheum Dis. 2018 Feb;77(2):212-220. doi: 10.1136/annrheumdis-2017-211682. Epub 2017 Oct 24.

45.

Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohort.

Mihai C, Antic M, Dobrota R, Bonderman D, Chadha-Boreham H, Coghlan JG, Denton CP, Doelberg M, Grünig E, Khanna D, McLaughlin VV, Müller-Ladner U, Pope JE, Rosenberg DM, Seibold JR, Vonk MC, Distler O.

Ann Rheum Dis. 2018 Jan;77(1):128-132. doi: 10.1136/annrheumdis-2017-211480. Epub 2017 Oct 23.

PMID:
29061853
46.

Through the Looking Glass: Specialty Influence on SCS Outcomes.

Boortz-Marx R, Qadri MYJ, Roy L, Pope JE, Deer TR, Runyon SL.

Neuromodulation. 2017 Oct;20(7):740-741. doi: 10.1111/ner.12694. No abstract available.

PMID:
29024484
47.

Trial methodology in scleroderma: Avoiding a shot in the dark.

Pope JE.

Rheumatology (Oxford). 2017 Sep 1;56(suppl_5):v1-v3. doi: 10.1093/rheumatology/kex204. No abstract available.

PMID:
28992175
48.

There is a need for new systemic sclerosis subset criteria. A content analytic approach.

Johnson SR, Soowamber ML, Fransen J, Khanna D, Van Den Hoogen F, Baron M, Matucci-Cerinic M, Denton CP, Medsger TA Jr, Carreira PE, Riemekasten G, Distler J, Gabrielli A, Steen V, Chung L, Silver R, Varga J, Müller-Ladner U, Vonk MC, Walker UA, Wollheim FA, Herrick A, Furst DE, Czirjak L, Kowal-Bielecka O, Del Galdo F, Cutolo M, Hunzelmann N, Murray CD, Foeldvari I, Mouthon L, Damjanov N, Kahaleh B, Frech T, Assassi S, Saketkoo LA, Pope JE.

Scand J Rheumatol. 2018 Jan;47(1):62-70. doi: 10.1080/03009742.2017.1299793. Epub 2017 Oct 9.

PMID:
28990485
49.

Multicenter Retrospective Study of Neurostimulation With Exit of Therapy by Explant.

Pope JE, Deer TR, Falowski S, Provenzano D, Hanes M, Hayek SM, Amrani J, Carlson J, Skaribas I, Parchuri K, McRoberts WP, Bolash R, Haider N, Hamza M, Amirdelfan K, Graham S, Hunter C, Lee E, Li S, Yang M, Campos L, Costandi S, Levy R, Mekhail N.

Neuromodulation. 2017 Aug;20(6):543-552. doi: 10.1111/ner.12634. Epub 2017 Jul 17.

PMID:
28714533
50.

Novel treatment strategies in rheumatoid arthritis.

Burmester GR, Pope JE.

Lancet. 2017 Jun 10;389(10086):2338-2348. doi: 10.1016/S0140-6736(17)31491-5. Review.

PMID:
28612748

Supplemental Content

Support Center